Prasad, C.B., Mahendru, D., Dahiwal, G., Gupta, J.B. and Nellisserry, J.J. 2022. Empagliflozin, Linagliptin, and Metformin in a triple fixed-dose combination for individuals with type 2 diabetes. Medico Research Chronicles. 9, 2 (Apr. 2022), 99-106. DOI:https://doi.org/10.26838/MEDRECH.2022.9.2.586.